Jeffrey Lazarus
doctorMale0.0Global Dominance: 0.00%
Dr. Jeffrey Lazarus is a public health expert at the City University of New York (CUNY) School of Public Health and Health Policy, who has been vocal about the need for effective treatments for metabolic liver diseases. He recently highlighted the breakthrough potential of semaglutide for patients with fatty liver disease and fibrotic conditions.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Dr Jeffrey Lazarus is the lead author of the paper and a professor of global health in New York and Barcelona.
Millions in west do not know they have aggressive fatty liver disease, study says | HealthThe Guardian·
United Kingdom· 2025-06-05
United Kingdom· 2025-06-05
Dr. Jeffrey Lazarus from the City University of New York School of Public Health and Health Policy describes the findings as groundbreaking news.
זריקת הרזיה וויגובי יעילה בטיפול במחלת כבד שומניידיעות אחרונות (Yedioth Ahronoth / ynet)·
Israel· 2025-05-03
Israel· 2025-05-03
